TVTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Travere Therapeutics, Inc.
Financials through Q2 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$50.49+0.89 (+1.79%)
Close on Oct 19, 2026
- Market cap
- $4.72B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Travere Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 21, 2026 | Sep 21, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 4, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 4, 2026 | Aug 4, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 6, 2026 | Jul 9, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2026 | Jun 16, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 1, 2026 | Jun 2, 2026 | SEC EDGAR |
| Current report | 8-K | May 19, 2026 | May 21, 2026 | SEC EDGAR |
| Current report | 8-K | May 6, 2026 | May 11, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 4, 2026 | SEC EDGAR |
| Current report | 8-K | May 4, 2026 | May 4, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 13, 2026 | Apr 14, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | May 19, 2026 | Apr 6, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 19, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 19, 2026 | Feb 19, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2026 | Jan 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Oct 30, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 30, 2025 | Oct 30, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 10, 2025 | Sep 10, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | May 15, 2025 | May 16, 2025 | SEC EDGAR |
| Current report | 8-K | May 15, 2025 | May 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 1, 2025 | SEC EDGAR |
| Current report | 8-K | May 1, 2025 | May 1, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 29, 2025 | Apr 30, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 15, 2025 | Apr 1, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 17, 2025 | Mar 17, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 21, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 20, 2025 | Feb 20, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 11, 2025 | Feb 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 8, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Oct 31, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 31, 2024 | Oct 31, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 26, 2024 | Sep 26, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 5, 2024 | Sep 6, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 1, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 1, 2024 | Aug 1, 2024 | SEC EDGAR |
| Current report | 8-K | May 8, 2024 | May 13, 2024 | SEC EDGAR |